Carmel Wroth

Many favorite holiday traditions could be treacherous this year, because of the coronavirus surge. Here's how experts view the risks — and some creative, safer alternatives to keep up a festive mood.

An independent federal advisory committee to the CDC recommends the Pfizer-BioNTech vaccine for people over 16. But state health leaders say distribution and funding challenges remain.

The President's diagnosis calls for contact tracing on a massive scale. Luckily, not everyone President Trump saw this week with is a high risk exposure. Here's who is.

As schools weigh the risks of reopening, many are making plans to lower the risks of coronavirus transmission. Here's how to vet your school's proposals.

A new color-coded map, backed by a coalition of top scientists, provides a way of comparing outbreak severity across communities, down to the county level.

The weather is warming up and public spaces are starting to reopen. How do you decide what's safe to do? We have guidance to help you compare and evaluate the risks.

New estimates say the U.S. needs to triple its testing. But how much testing does each state need? Here's how states compare to each other, and to targets experts say they should hit.

The preliminary results showed that hospitalized patients who received remdesivir recovered 31% faster. Dr. Anthony Fauci hailed the findings as "quite good news."

There are rumblings that U.S. health officials may start encouraging Americans to wear face masks to cut down on asymptomatic spread. But with continued shortages, it's not clear how we'd do that.

Federal agencies are working furiously to find out what is causing people to sicken and are warning consumers not to vape.